Cite

    Waljee, A. K., Higgins, P. D. R., Jensen, C. B., Villumsen, M., Cohen-Mekelburg, S. A., Wallace, B. I., Berinstein, J. A., Allin, K. H., & Jess, T. (2020). anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study. Lancet gastroenterology and hepatology, 5, 276–284. http://access.bl.uk/ark:/81055/vdc_100101476325.0x000002